Literature DB >> 18977033

Salivary cortisol in unaffected twins discordant for affective disorder.

Maj Vinberg1, Bente Bennike, Kirsten Ohm Kyvik, Per Kragh Andersen, Lars Vedel Kessing.   

Abstract

Dysfunction in the hypothalamic-pituitary-adrenal (HPA) axis has been proposed as a biological endophenotype for affective disorders. In the present study the hypothesis that a high genetic liability to affective disorder is associated with higher cortisol levels was tested in a cross-sectional high-risk study. Healthy monozygotic (MZ) and dizygotic (DZ) twins with (High-Risk twins) and without (Low-Risk twins) a co-twin history of affective disorder were identified through nationwide registers. Awakening and evening salivary cortisol levels were compared between the 190 High- and Low-Risk twins. The 109 High-Risk twins had significantly higher evening cortisol levels than the 81 Low-Risk MZ twins, also after adjustment for age, sex, and the level of subclinical depressive symptoms. No significant difference was found in awakening cortisol levels between High-Risk and Low-Risk twins. In conclusion, a high genetic liability to affective disorder was associated with a higher evening cortisol level, but not with awakening cortisol level. Future prospective family, high-risk and twin studies are needed to decide whether abnormalities in the HPA axis can be identified as an endophenotype of affective disorder.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18977033     DOI: 10.1016/j.psychres.2007.08.001

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  6 in total

1.  Effects of early-life adversity on white matter diffusivity changes in patients at risk for major depression.

Authors:  Thomas Frodl; Angela Carballedo; Andrew J Fagan; Danuta Lisiecka; Yolande Ferguson; James F Meaney
Journal:  J Psychiatry Neurosci       Date:  2012-01       Impact factor: 6.186

2.  Cortisol at the emergency room rape visit as a predictor of PTSD and depression symptoms over time.

Authors:  Kate Walsh; Nicole R Nugent; Amelia Kotte; Ananda B Amstadter; Sheila Wang; Constance Guille; Ron Acierno; Dean G Kilpatrick; Heidi S Resnick
Journal:  Psychoneuroendocrinology       Date:  2013-06-24       Impact factor: 4.905

3.  Cortisol secretion in depressed, and at-risk adults.

Authors:  Kimberly A Dienes; Nicholas A Hazel; Constance L Hammen
Journal:  Psychoneuroendocrinology       Date:  2012-11-02       Impact factor: 4.905

4.  Escitalopram and neuroendocrine response in healthy first-degree relatives to depressed patients--a randomized placebo-controlled trial.

Authors:  Ulla Knorr; Maj Vinberg; Allan Hansen; Marianne Klose; Ulla Feldt-Rasmussen; Linda Hilsted; Jørgen Hasselstrøm; Ulrik Gether; Per Winkel; Christian Gluud; Jørn Wetterslev; Lars Vedel Kessing
Journal:  PLoS One       Date:  2011-06-27       Impact factor: 3.240

5.  Cortisol awakening response and subsequent depression: prospective longitudinal study.

Authors:  Rebecca Carnegie; Ricardo Araya; Yoav Ben-Shlomo; Vivette Glover; Thomas G O'Connor; Kieran J O'Donnell; Rebecca Pearson; Glyn Lewis
Journal:  Br J Psychiatry       Date:  2013-12-05       Impact factor: 9.319

6.  Cortisol awakening response is linked to disease course and progression in multiple sclerosis.

Authors:  Simone Kern; Ivonne Krause; Antje Horntrich; Katja Thomas; Julia Aderhold; Tjalf Ziemssen
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.